Product
PSMA-11
2 clinical trials
2 indications
Indication
Prostate CancerClinical trial
Managed Access Program (MAP) Cohort Treatment Plan [CAAA617A12001M] to Provide Access to 177Lu-PSMA-617 for Patients With Metastatic Castration-resistant Prostate Cancer.Status:
Clinical trial
18F-DCFPyL PET/CT in High Risk and Recurrent Prostate CancerStatus: , Estimated PCD: 2029-12-31